Boston Scientific to pay $230M for majority stake in devicemaker

Marlborough, Mass.-based Boston Scientific entered into a definitive agreement to shell out $230 million for Synergy’s M.I. Tech, a medical device manufacturer and distributor, for a 64 percent stake by the end of 2022.

Advertisement

M.I. Tech specializes in devices for endoscopic and urologic procedures, according to the June 15 press release. The deal is subject to customary closing conditions.

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.